In our analyses we found that in MSI CRCs a negligible fraction of these tumor-associated PD-1+ NK cells expressed CD57 (classic marker of terminally differentiated NK cells in PB), while the majority of them expressed the tissue residency markers CD103 and/or CD49a (trNK cells). This evidence concerns the gene B3GAT1 and neoplasm.